Announced
Financials
Sources
Tags
Acquisition
Private Equity
Medical Services
Merger
Single Bidder
United States
pathology services
Majority
Pending
Private
Friendly
Synopsis
Ampersand Capital Partners-backed StageBio, a provider of GLP-compliant research and preclinical histology, pathology and specimen archiving services, agreed to merge with Alizée Pathology, a preclinical medical device laboratory in North America. Financial terms were not disclosed. "Dr. Serge Rousselle, Dr. Joan Wicks and the Alizée staff bring unique histopathology capabilities to StageBio. These services enable us to offer the industry an even broader range of highly specialized histopathology and imaging services. We have successfully merged HSRL, VPS and TPS, and are excited to add Alizée's expertise to our growing list of offerings," Thomas Galati, StageBio CEO.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.